These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 35253782)
1. T Lymphocytes in Parkinson's Disease. Contaldi E; Magistrelli L; Comi C J Parkinsons Dis; 2022; 12(s1):S65-S74. PubMed ID: 35253782 [TBL] [Abstract][Full Text] [Related]
2. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease. Campos-Acuña J; Elgueta D; Pacheco R Front Immunol; 2019; 10():239. PubMed ID: 30828335 [TBL] [Abstract][Full Text] [Related]
3. The role of T cells in the pathogenesis of Parkinson's disease. Chen Z; Chen S; Liu J Prog Neurobiol; 2018 Oct; 169():1-23. PubMed ID: 30114440 [TBL] [Abstract][Full Text] [Related]
4. The role of innate and adaptive immunity in Parkinson's disease. Kannarkat GT; Boss JM; Tansey MG J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605 [TBL] [Abstract][Full Text] [Related]
5. T lymphocyte senescence is attenuated in Parkinson's disease. Kouli A; Jensen M; Papastavrou V; Scott KM; Kolenda C; Parker C; Solim IH; Camacho M; Martin-Ruiz C; Williams-Gray CH J Neuroinflammation; 2021 Oct; 18(1):228. PubMed ID: 34645462 [TBL] [Abstract][Full Text] [Related]
6. The key role of T cells in Parkinson's disease pathogenesis and therapy. Baird JK; Bourdette D; Meshul CK; Quinn JF Parkinsonism Relat Disord; 2019 Mar; 60():25-31. PubMed ID: 30404763 [TBL] [Abstract][Full Text] [Related]
7. Role of CD4+ T Cells in Parkinson's Disease. Ghanta MK; Nuthalapati P; Merchant N; Chenchula S; Hussain F; Ak AK; Bhaskar LVKS Crit Rev Immunol; 2022; 42(6):17-25. PubMed ID: 37082948 [TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients. Kustrimovic N; Comi C; Magistrelli L; Rasini E; Legnaro M; Bombelli R; Aleksic I; Blandini F; Minafra B; Riboldazzi G; Sturchio A; Mauri M; Bono G; Marino F; Cosentino M J Neuroinflammation; 2018 Jul; 15(1):205. PubMed ID: 30001736 [TBL] [Abstract][Full Text] [Related]
9. Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson's disease patients in a two-year follow-up: a case control study. Álvarez-Luquín DD; Guevara-Salinas A; Arce-Sillas A; Espinosa-Cárdenas R; Leyva-Hernández J; Montes-Moratilla EU; Adalid-Peralta L J Transl Med; 2021 Sep; 19(1):378. PubMed ID: 34488776 [TBL] [Abstract][Full Text] [Related]
10. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease. Tan JSY; Chao YX; Rötzschke O; Tan EK Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291304 [TBL] [Abstract][Full Text] [Related]
13. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease. Contaldi E; Magistrelli L; Comi C Handb Clin Neurol; 2023; 193():67-93. PubMed ID: 36803824 [TBL] [Abstract][Full Text] [Related]
14. Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson's Disease. Contaldi E; Magistrelli L; Milner AV; Cosentino M; Marino F; Comi C J Parkinsons Dis; 2021; 11(2):507-514. PubMed ID: 33386815 [TBL] [Abstract][Full Text] [Related]